Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Aripiprazole”

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT01663532
What this trial is testing

Trial of Aripiprazole Intramuscular Depot (OPC-14597, Lu AF41155) in the Acute Treatment of Adults With Schizophrenia

Who this might be right for
Schizophrenia
Otsuka Pharmaceutical Development & Commercialization, Inc. 340
Large-scale testing (Phase 3)Study completedNCT00884884
What this trial is testing

Aripiprazole and Topiramate on Free-Choice Alcohol Use

Who this might be right for
Alcohol Dependence
National Institute on Alcohol Abuse and Alcoholism (NIAAA) 90
Not applicableStudy completedNCT03179787
What this trial is testing

Post-Marketing Surveillance Study of Aripiprazole in Patients With Autism

Who this might be right for
Autism
Otsuka Pharmaceutical Co., Ltd. 528
Post-approval studies (Phase 4)Ended earlyNCT02357849
What this trial is testing

Fluoxetine vs Aripiprazole Comparative Trial (FACT)

Who this might be right for
Attenuated Psychosis Syndrome
Northwell Health 9
Not applicableStudy completedNCT01284218
What this trial is testing

Retrospective Database Study of Real World Abilify Outcomes in Major Depressive Disorder (MDD)

Who this might be right for
Depressive Disorder, Major
Otsuka Pharmaceutical Development & Commercialization, Inc. 23,514
Early research (Phase 1)Study completedNCT00276874
What this trial is testing

Aripiprazole to Reduce Cocaine Relapse

Who this might be right for
Cocaine-Related Disorders
Craig Rush 41
Testing effectiveness (Phase 2)Study completedNCT00580125
What this trial is testing

Dose-response Study to Evaluate Safety, Efficacy, and Pharmacokinetics of PF-00217830 Compared With Placebo in Acute Exacerbation of Schizophrenia

Who this might be right for
Schizophrenia
Pfizer 164
Post-approval studies (Phase 4)Study completedNCT00241176
What this trial is testing

Open Label Trial of Aripiprazole in Children and Adolescents With Tourette's Disorder

Who this might be right for
Tourette's SyndromeTic Disorders
NYU Langone Health 11
Post-approval studies (Phase 4)Study completedNCT01207414
What this trial is testing

Switching to Iloperidone From Other Antipsychotics in Schizophrenia

Who this might be right for
Schizophrenia
Novartis 501
Large-scale testing (Phase 3)Ended earlyNCT01509053
What this trial is testing

Open-label Study to Compare Hospitalization Rates of Schizophrenic Patients Treated With Oral Antipsychotics Versus IM Depot Aripiprazole

Who this might be right for
Schizophrenia
Otsuka Pharmaceutical Development & Commercialization, Inc. 30
Post-approval studies (Phase 4)WithdrawnNCT01155544
What this trial is testing

Improving Outcomes in Psychosis Associated With Substance Use Using Aripiprazole

Who this might be right for
Substance AbuseSubstance Dependence
Northwell Health
Post-approval studies (Phase 4)Study completedNCT00845988
What this trial is testing

Metabolic Effects of Switching to Aripiprazole in Patients With Bipolar Disorders

Who this might be right for
Bipolar DisordersMetabolic Complication
Seoul National University Hospital 28
Early research (Phase 1)Study completedNCT01909466
What this trial is testing

Safety and Tolerability Study of Aripiprazole IM Depot in Adult Subjects With Schizophrenia

Who this might be right for
SchizophreniaMental DisorderNervous System Diseases
Otsuka Pharmaceutical Development & Commercialization, Inc. 141
Large-scale testing (Phase 3)Study completedNCT03487770
What this trial is testing

Aripiprazole Oral Solution in the Treatment of Children and Adolescents With Autistic Disorder

Who this might be right for
Autistic Disorder
Otsuka Beijing Research Institute 111
Post-approval studies (Phase 4)Ended earlyNCT00712270
What this trial is testing

Best Event Schizophrenia Trial--A Randomized Double-Blind Trial of Aripiprazole and Risperidone in Schizophrenia

Who this might be right for
Schizophrenia
Kettering Health Network 21
Large-scale testing (Phase 3)Study completedNCT01727700
What this trial is testing

Study Evaluating the Safety and Efficacy of Fixed-dose Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder

Who this might be right for
Tourette's DisorderTic Disorder
Otsuka Pharmaceutical Development & Commercialization, Inc. 133
Testing effectiveness (Phase 2)Study completedNCT00905307
What this trial is testing

Study to Evaluate the Efficacy, Safety, and Tolerability of Oral OPC-34712 and Aripiprazole for Treatment of Acute Schizophrenia

Who this might be right for
Schizophrenia
Otsuka Pharmaceutical Development & Commercialization, Inc. 459
Early research (Phase 1)Study completedNCT02320032
What this trial is testing

An Open-Label Study of Aripiprazole Lauroxil in Subjects With Stable Schizophrenia

Who this might be right for
Schizophrenia
Alkermes, Inc. 140
Large-scale testing (Phase 3)Study completedNCT01292057
What this trial is testing

Aripiprazole Effects on Alcohol Drinking and Craving

Who this might be right for
Alcohol Dependence
Medical University of South Carolina 99
Not applicableUnknownNCT01488266
What this trial is testing

Aripiprazole Augmentation Versus Switching to Different Class of Antidepressants in Major Depressive Disorder

Who this might be right for
Major Depressive Disorder
Korea University 90
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation